戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1  of COVID-19 from those of other diseases, which can appear similar in the first instance.
2 ary constraints among sequence, structure, and function are similar in structured RNA and proteins.
3 een SUN and the C-terminal residues of the KASH peptide are similar in all five complexes, the extended KASH-peptide adop
4                 Many neuronal types occur as pairs that are similar in most respects but differ in a key feature.
5 verall, the data reveal that Entamoeba secrete EVs that are similar in size and shape to previously characterized exosome
6        Comparison to prior work indicates that these TS are similar in nature to those for the alkaline hydrolysis of neu
7                             Both BPV-1 and HPV-31 Y102E are similar in that neither binds the C terminus of Brd4, but in
8 le the dynamics of biological and cultural evolution may be similar in principle the underlying mechanisms and time scale
9                          Here, we show that although highly similar in sequence, some of the plant JDPs are functionally
10               The absolute magnitude of splicing changes is similar in pre-symptomatic and late stage tissue.
11                                Moreover, this clustering is similar in yeast and human kinetochores despite significant d
12                              Since the timing of disease is similar in humans and AGMs, these AGM data are reasonably lik
13 0 cells, the underlying actin guidance by nanotopography is similar in both cell types at the micron and submicron scales
14                 OHTS DH had densitometric measurements more similar in magnitude to adjacent arterioles than venules, sup
15 A panel of patient-derived ovarian cancer xenografts (PDX), similar in genetics and chemotherapy responsiveness to human
16   Renal function and donor-specific HLA-antibodies remained similar in both groups.
17 mean=10.08, 95% CI 2.66 to 17.50, p=0.010), while it stayed similar in pain-free patients (Deltamean=2.74, 95% CI -7.36 t
18 e that the nuclear organization of the diencephalon is very similar in the two species, and similar to that reported in o
19 ive complications (P = .17) and interventions (P = .10) was similar in all groups.
20  or clinical grade 3 or 4 adverse events through day 5) was similar in the LY-CoV555 group and the placebo group (19% and
21  of adverse events leading to treatment discontinuation was similar in both groups (KdD, 69 [22%]; Kd, 38 [25%]).
22                    The number of serious adverse events was similar in both groups and unrelated to the intervention (POP
23 e of participants with local or systemic adverse events was similar in the two groups.
24 atients during follow-up, and the extent of improvement was similar in both study groups.
25  complexity of the systemic inflammatory/immune network was similar in IRF3-KO versus WT septic mice, although the tempo
26                        In the second survey, prevalence was similar in men and women, but an increased prevalence was obs
27                       The overall 30-day mortality rate was similar in both time periods (1.8% versus 1.4%, P=0.457).
28                                              Recurrence was similar in patients receiving PMRT compared to those that did
29                                          Mortality risk was similar in participants with >0.5-1.0 nmol/L compared with >1
30 t significantly different in TRPC1/6(-/-) pmLF and ROCE was similar in STIM1/2-deficient pmLF compared to Wt cells.
31      Hepatic fat, insulin sensitivity index, and SCD-1 were similar in black women and lower than in whites, regardless o
32 ne uptake and system L amino acid transporter activity were similar in sarcolemmal membranes isolated from control and IU
33 rcass, whilst females that had cared for a large brood were similar in competitive ability to virgin females.
34   Preoperative CV, percent of hexagonal cells, and CCT were similar in both groups and remained stable.
35                  The rates of hospitalization or death were similar in the two groups.
36 s, including severity of pain and level of disability, were similar in the two groups.
37             Cumulative rates of serious adverse events were similar in TAK-003 (4.0%) and placebo (4.8%) recipients, and
38                                         Adverse events were similar in the two trial groups, with no notable hypersensiti
39 t follow-up, eyes that returned to OR and control eyes were similar in terms of mean intraocular pressure (IOP), the prop
40                                             The groups were similar in age and risk factors.
41                                                 Groups were similar in the incidence of reoperation, vascular thrombosis,
42                   Pretransplant, M-MDSC, and monocytes were similar in KTRs and healthy volunteers.
43  mitochondrially encoded and synthesized protein mtCO1 were similar in mitochondria from YAC128 mice and their wild-type
44                               Other secondary outcomes were similar in the two groups.
45 roteins in the mechanistic target of rapamycin pathway were similar in control and IUGR skeletal muscle homogenate.
46                   However, surgical complication rates were similar in both groups.
47                                            The results were similar in inverse probability of treatment and censoring wei
48                                                Results were similar in multiple sensitivity analyses.
49                                      Bayley III scores were similar in the IVB and control groups, except for a minor dif
50                             Cases and control subjects were similar in age, sex, and cancer type.